全球储能领域的"老大"与"老三"正面交锋始于2023年。当年9月，宁德时代起诉海辰储能创始人吴祖钰违反竞业协议，后者最终支付了100万元违约金。 长江商报消息 ●长江商报记者 沈右荣 万亿"宁王"与储能"新贵"的商业纠纷，因为一封《求助信》再度成为关注焦点。 9月15日晚间，自称"冯登科妻子"的用户通过微信公众号发布一封《求助信》，信中称其丈夫、海辰储能前总裁办主任和工程部负责人冯登科被宁德时代指控侵犯商业秘密而遭逮捕。 冯登科妻子在信中质疑这是一场"恶性商战"，并称其丈夫可能成为牺牲品。 截至目前，宁德时代（300750.SZ）及海辰储能科技股份有限公司（以下简称"海辰储能"）均未对此做出回应。 2025年3月25日，成立仅6年的海辰储能向港股递表，开启IPO征程。公司多名高层有宁德时代工作经历。 公开信息显示，2023年以来，宁德时代已经四次出手狙击海辰储能，其中三次为直接诉讼。 近几年，海辰储能营业收入高速增长，2024年达到129亿元，公司估值250亿元。 截至2025年6月，宁德时代拥有及正在申请专利达49347件，是海辰储能的12.65倍。 遭宁德时代狙击，海辰储能的IPO充满变数。 "老大"与" ...

Core Viewpoint - The commercial dispute between Ningde Times and Haicheng Energy Storage has gained attention due to a "help request letter" from the wife of a former executive at Haicheng, who was arrested for allegedly infringing on trade secrets. This incident highlights the ongoing patent conflict between the two companies, with Haicheng's IPO facing uncertainties as a result [2][10]. Company Overview - Haicheng Energy Storage, founded on December 27, 2019, focuses on the research, production, and sales of lithium battery core materials and lithium iron phosphate energy storage batteries. The company plans to list on the Hong Kong Stock Exchange on March 25, 2025 [3][10]. - As of 2024, Haicheng is the only company in the GWh-level lithium-ion battery shipment category that specializes in the energy storage sector, ranking third globally in energy storage battery shipments [3]. Market Position and Performance - In 2024 and the first half of 2025, Ningde Times maintained its position as the global leader in energy storage battery sales, with shipments of 93 GWh and 55 GWh, respectively [4]. - Haicheng's energy storage battery shipments grew at a compound annual growth rate of 167% from 2022 to 2024, reaching 35.1 GWh in 2024, capturing an 11% market share [15]. Financial Performance - Haicheng's revenue has seen rapid growth, with figures of 3.615 billion yuan, 10.202 billion yuan, and 12.917 billion yuan from 2022 to 2024, representing a 2.57-fold increase over two years. The company turned a profit in 2024, achieving a net profit of 318 million yuan after adjustments [15]. Patent Dispute - The patent conflict between Ningde Times and Haicheng has escalated, with Ningde Times filing multiple lawsuits against Haicheng, including a claim for 150 million yuan for unfair competition [4][10]. - As of June 2025, Ningde Times holds 49,347 patents, significantly outnumbering Haicheng's 3,900 patents [15]. Key Personnel and Background - Haicheng's key personnel, including its founder Wu Zuyu, have backgrounds in Ningde Times, which has contributed to the company's rapid rise. Wu worked at Ningde Times for over seven years before founding Haicheng [10][11].

Core Viewpoint - The legal dispute between Masimo and Apple centers around the blood oxygen functionality in Apple Watches, with Masimo alleging that U.S. Customs and Border Protection (CBP) improperly allowed Apple to import watches equipped with pulse oximeter technology without consulting Masimo [1][3]. Group 1: Legal Dispute - Masimo has filed a lawsuit against CBP in federal court, claiming that the agency reversed its previous decision regarding the importation of Apple Watches with blood oxygen reading capabilities without notifying Masimo [3]. - The conflict between Masimo and Apple has been ongoing, with Masimo accusing Apple of poaching its employees and stealing technology for the pulse oximeter used in Apple Watches [3]. - In 2023, Masimo successfully convinced the U.S. International Trade Commission (ITC) to block the import of Apple Series 9 and Ultra 2 smartwatches due to patent infringement related to blood oxygen level reading technology [3]. Group 2: Recent Developments - On August 14, Apple announced it would reintroduce the blood oxygen reading feature in its smartwatches, contingent upon CBP's approval, which Masimo argues was granted without proper consultation [3]. - Masimo contends that CBP's actions undermine its rights and responsibilities, emphasizing that the agency should enforce the ITC's exclusion order rather than create loopholes [3]. - Masimo is seeking a court order to halt CBP's decision and prevent Apple from selling watches with blood oxygen functionality [3].